TSX:OPS

Stock Analysis Report

Executive Summary

Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications.

Snowflake

Fundamentals

Adequate balance sheet with reasonable growth potential.

Share Price & News

How has Opsens's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

2.3%

OPS

-4.1%

CA Medical Equipment

-0.2%

CA Market


1 Year Return

7.1%

OPS

-19.6%

CA Medical Equipment

1.5%

CA Market

Return vs Industry: OPS exceeded the Canadian Medical Equipment industry which returned -19.6% over the past year.

Return vs Market: OPS exceeded the Canadian Market which returned 1.5% over the past year.


Shareholder returns

OPSIndustryMarket
7 Day2.3%-4.1%-0.2%
30 Day4.7%-19.8%-3.5%
90 Day-4.3%-20.4%-1.8%
1 Year7.1%7.1%-19.6%-19.6%5.1%1.5%
3 Year-42.7%-42.7%-53.5%-53.5%13.3%3.2%
5 Year50.0%50.0%-13.4%-13.4%25.2%7.2%

Price Volatility Vs. Market

How volatile is Opsens's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Opsens undervalued compared to its fair value and its price relative to the market?

4.3x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate OPS's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate OPS's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: OPS is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.

PE vs Market: OPS is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate OPS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: OPS is good value based on its PB Ratio (4.3x) compared to the CA Medical Equipment industry average (5x).


Next Steps

Future Growth

How is Opsens forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

96.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: OPS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).

Earnings vs Market: OPS is forecast to become profitable over the next 3 year, which is considered above average market growth.

High Growth Earnings: OPS's loss is forecast to worsen by 0% next year.

Revenue vs Market: OPS's revenue (18.5% per year) is forecast to grow faster than the Canadian market (5.7% per year).

High Growth Revenue: OPS's revenue (18.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if OPS's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Opsens performed over the past 5 years?

-2.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: OPS is unprofitable, and losses have increased over the past 5 years at a rate of -2.9% per year.

Accelerating Growth: Unable to compare OPS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: OPS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (27.4%).


Return on Equity

High ROE: OPS has a negative Return on Equity (-9.74%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: OPS is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: OPS is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Opsens's financial position?


Financial Position Analysis

Short Term Liabilities: OPS's short term assets (CA$27.4M) exceeds its short term liabilities (CA$4.6M)

Long Term Liabilities: OPS's short term assets (27.4M) exceeds its long term liabilities (7.9M)


Debt to Equity History and Analysis

Debt Level: OPS's debt to equity ratio (40.2%) is considered high

Reducing Debt: OPS's debt to equity ratio has increased from 36.9% to 40.2% over the past 5 years.


Balance Sheet

Inventory Level: OPS has a high level of physical assets or inventory.

Debt Coverage by Assets: OPS's debt is covered by short term assets (assets are 3.617240x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: OPS has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: OPS has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 63.2% each year


Next Steps

Dividend

What is Opsens's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.0%markettop25%6.0%industryaverage1.2%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate OPS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate OPS's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if OPS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if OPS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of OPS's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

What is the CEO of Opsens's salary, the management and board of directors tenure and is there insider trading?

3.2yrs

Average management tenure


CEO

Louis Laflamme 0

6.8yrs

Tenure

CA$307,798

Compensation

Mr. Louis Laflamme, C.A, C.P.A., has been the Chief Executive Officer and President of Opsens Inc. since January 7, 2013. Mr. Laflamme’s primary mandate is to see to the operational management of the Corpo ...


CEO Compensation Analysis

Compensation vs. Market: Louis's total compensation ($USD234.35K) is about average for companies of similar size in the Canadian market ($USD131.81K).

Compensation vs Earnings: Louis's compensation has increased whilst the company is unprofitable.


Management Age and Tenure

3.2yrs

Average Tenure

Experienced Management: OPS's management team is considered experienced (3.2 years average tenure).


Board Age and Tenure

6.8yrs

Average Tenure

55yo

Average Age

Experienced Board: OPS's board of directors are considered experienced (6.8 years average tenure).


Insider Trading

Insider Buying: OPS insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyCA$5,85025 Aug 19
Alan Milinazzo
EntityIndividual
Role
Chairman of the Board
Executive Chairman
Shares9,000
Max PriceCA$0.65
BuyCA$10,59325 Jul 19
Alan Milinazzo
EntityIndividual
Role
Chairman of the Board
Executive Chairman
Shares14,499
Max PriceCA$0.74
BuyCA$9,28323 Jul 19
Alan Milinazzo
EntityIndividual
Role
Chairman of the Board
Executive Chairman
Shares9,999
Max PriceCA$0.93
BuyCA$5,52016 Jul 19
Robin Villeneuve
EntityIndividual
Role
Chief Financial Officer
CFO & Corporate Secretary
Shares6,000
Max PriceCA$0.92
SellCA$90031 May 19
Fiera Capital Corporation
EntityCompany
Shares1,000
Max PriceCA$0.90
SellCA$149,95629 May 19
Fiera Capital Corporation
EntityCompany
Shares166,500
Max PriceCA$0.90
SellCA$2,25024 May 19
Fiera Capital Corporation
EntityCompany
Shares2,500
Max PriceCA$0.90
SellCA$126,94122 May 19
Fiera Capital Corporation
EntityCompany
Shares141,000
Max PriceCA$0.93
SellCA$93017 May 19
Fiera Capital Corporation
EntityCompany
Shares1,000
Max PriceCA$0.93
SellCA$16,31308 May 19
Fiera Capital Corporation
EntityCompany
Shares17,500
Max PriceCA$0.93
SellCA$4,70603 May 19
Fiera Capital Corporation
EntityCompany
Shares1,693,072
Max PriceCA$0.94

Ownership Breakdown


Management Team

  • Alan Milinazzo (59yo)

    Executive Chairman

    • Tenure: 0.6yrs
  • Claude Belleville

    Consultant

    • Tenure: 1.5yrs
    • Compensation: CA$252.33k
  • Louis Laflamme

    President

    • Tenure: 6.8yrs
    • Compensation: CA$307.80k
  • Gaétan Duplain

    President of Solutions & Director

    • Tenure: 13yrs
    • Compensation: CA$240.98k
  • Robin Villeneuve (52yo)

    CFO & Corporate Secretary

    • Tenure: 2.3yrs
    • Compensation: CA$218.88k
  • Pierre Poulin

    Corporate Controller

    • Tenure: 0yrs

Board Members

  • Alan Milinazzo (59yo)

    Executive Chairman

    • Tenure: 0.6yrs
  • Jean Lavigueur (58yo)

    Independent Director

    • Tenure: 7.8yrs
    • Compensation: CA$39.75k
  • Louis Laflamme

    President

    • Tenure: 6.8yrs
    • Compensation: CA$307.80k
  • Denis Sirois (48yo)

    Independent Director

    • Tenure: 13.6yrs
    • Compensation: CA$40.25k
  • Gaétan Duplain

    President of Solutions & Director

    • Tenure: 13yrs
    • Compensation: CA$240.98k
  • Pat MacKin (52yo)

    Independent Director

    • Tenure: 3.1yrs
    • Compensation: CA$26.15k
  • Denis Harrington

    Director

    • Tenure: 4.8yrs
    • Compensation: CA$30.40k

Company Information

Opsens Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Opsens Inc.
  • Ticker: OPS
  • Exchange: TSX
  • Founded:
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CA$81.099m
  • Shares outstanding: 90.11m
  • Website: https://opsens.com

Number of Employees


Location

  • Opsens Inc.
  • 750, Boulevard du ParcTechnologique
  • Québec
  • Quebec
  • G1P 4S3
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
OPSTSX (The Toronto Stock Exchange)YesCategory A SharesCACADMay 2006
OPSS.FOTCPK (Pink Sheets LLC)YesCategory A SharesUSUSDMay 2006
5OPDB (Deutsche Boerse AG)YesCategory A SharesDEEURMay 2006

Biography

Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates thro ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/20 23:55
End of Day Share Price2019/10/18 00:00
Earnings2019/05/31
Annual Earnings2018/08/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.